Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MK-8294 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on MK-8294 (Aug 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MK-8294 | MK 8294|MK8294|DAB-014236|DAB 014236|DAB014236 | Limited information is currently available on MK-8294 (Aug 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07030712 | Phase I | MK-8294 | A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001) | Recruiting | USA | NLD | ISR | 0 |